Fenoplast Ltd
Fenoplast is engaged in a market leader in the OEM segment for Faux Leather and is known for its commitment to quality and impeccable service to its customers.
- Market Cap ₹ 6.00 Cr.
- Current Price ₹ 13.0
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 65.1
- Dividend Yield 0.00 %
- ROCE -16.4 %
- ROE -92.3 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.20 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -14.1% over past five years.
- Company has a low return on equity of -41.9% over last 3 years.
- Contingent liabilities of Rs.12.6 Cr.
- Company's cost of borrowing seems high
- Working capital days have increased from 149 days to 217 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Plastic products Industry: Plastics Products
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
110 | 144 | 176 | 196 | 194 | 219 | 237 | 223 | 225 | 237 | 186 | 111 | |
98 | 129 | 162 | 179 | 177 | 212 | 219 | 205 | 206 | 227 | 176 | 126 | |
Operating Profit | 12 | 15 | 14 | 18 | 18 | 6 | 19 | 19 | 18 | 11 | 10 | -15 |
OPM % | 11% | 10% | 8% | 9% | 9% | 3% | 8% | 8% | 8% | 4% | 5% | -13% |
1 | 1 | 1 | 0 | 1 | 12 | 1 | 1 | 0 | 9 | 7 | 27 | |
Interest | 8 | 10 | 10 | 12 | 14 | 14 | 15 | 16 | 16 | 15 | 14 | 12 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Profit before tax | 3 | 3 | 4 | 4 | 3 | 2 | 2 | 1 | 1 | 3 | 1 | -2 |
Tax % | 49% | 34% | 33% | 34% | 36% | 24% | 25% | 35% | 22% | 14% | 46% | 4% |
1 | 2 | 2 | 3 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | -2 | |
EPS in Rs | 2.87 | 4.78 | 5.41 | 5.80 | 3.59 | 3.67 | 3.87 | 1.35 | 1.39 | 4.80 | 1.46 | -5.26 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | -3% |
5 Years: | -14% |
3 Years: | -21% |
TTM: | -40% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -451% |
Stock Price CAGR | |
---|---|
10 Years: | -9% |
5 Years: | -6% |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | -12% |
5 Years: | -23% |
3 Years: | -42% |
Last Year: | -92% |
Balance Sheet
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Reserves | 24 | 25 | 27 | 29 | 30 | 31 | 32 | 32 | 26 | 27 | 28 | 25 |
49 | 50 | 50 | 54 | 58 | 64 | 64 | 66 | 69 | 63 | 69 | 67 | |
27 | 38 | 45 | 44 | 51 | 66 | 71 | 63 | 68 | 77 | 51 | 40 | |
Total Liabilities | 104 | 118 | 127 | 132 | 143 | 165 | 171 | 166 | 168 | 172 | 152 | 137 |
36 | 34 | 33 | 34 | 33 | 34 | 34 | 33 | 27 | 28 | 30 | 31 | |
CWIP | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 |
Investments | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
68 | 84 | 94 | 98 | 111 | 131 | 137 | 133 | 139 | 143 | 121 | 106 | |
Total Assets | 104 | 118 | 127 | 132 | 143 | 165 | 171 | 166 | 168 | 172 | 152 | 137 |
Cash Flows
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-1 | 7 | 11 | 12 | 11 | 1 | 17 | 16 | 14 | 15 | 6 | -14 | |
-6 | 0 | -2 | -5 | -1 | 7 | -3 | -1 | -1 | 6 | 3 | 24 | |
7 | -7 | -8 | -8 | -8 | -8 | -15 | -14 | -14 | -21 | -11 | -10 | |
Net Cash Flow | -0 | -0 | 1 | -0 | 2 | 0 | -1 | 1 | -1 | 0 | -2 | -0 |
Ratios
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 128 | 133 | 116 | 105 | 129 | 133 | 125 | 128 | 126 | 117 | 93 | 120 |
Inventory Days | 55 | 57 | 62 | 62 | 64 | 79 | 84 | 86 | 106 | 111 | 174 | 248 |
Days Payable | 77 | 98 | 87 | 74 | 98 | 101 | 109 | 108 | 119 | 118 | 93 | 103 |
Cash Conversion Cycle | 106 | 92 | 91 | 92 | 95 | 111 | 100 | 107 | 112 | 110 | 174 | 265 |
Working Capital Days | 135 | 118 | 90 | 90 | 99 | 102 | 98 | 108 | 107 | 103 | 126 | 217 |
ROCE % | 15% | 17% | 17% | 19% | 18% | 5% | 17% | 17% | 17% | 10% | 9% | -16% |
Documents
Announcements
-
Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
28 Mar - Cancellation of equity shares and new share issuance.
-
Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
27 Mar - Approval of resolution plan for M/s. Fenoplast Limited.
-
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
9 Sep 2024 - Outcome of 25th Committee of Creditors Meeting.
-
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
27 Aug 2024 - Outcome of 24th CoC meeting regarding resolution plans.
-
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
25 Jul 2024 - Outcome of 23rd CoC meeting regarding CIRP.